Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Bordeleau, J.-M.
Albert, J.-M.
Hillel, J.
and
Tetreault, L.
1967.
Medication Antiparkinsonienne et Bilan Extra-Pyramidal: Etude du Trihexyphenidyl.
Canadian Psychiatric Association Journal,
Vol. 12,
Issue. 6,
p.
585.
BOWMAN, W. C.
and
NOTT, M. W.
1970.
Actions of some sympathomimetic bronchodilator and beta‐adrenoceptor blocking drugs on contractions of the cat soleus muscle.
British Journal of Pharmacology,
Vol. 38,
Issue. 1,
p.
37.
DiMascio, Alberto
and
Demirgian, Edward
1970.
Antiparkinson Drug Overuse.
Psychosomatics,
Vol. 11,
Issue. 6,
p.
596.
Mindham, R. H. S.
Gaind, R.
Anstee, B. H.
and
Rimmer, Lorna
1972.
Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
Psychological Medicine,
Vol. 2,
Issue. 4,
p.
406.
McClelland, H. A.
Blessed, G.
Ali, N.
Bhate, S.
and
Clarke, P. A.
1974.
The Abrupt Withdrawal of Antiparkinsonian Drugs in Schizophrenic Patients.
British Journal of Psychiatry,
Vol. 124,
Issue. 579,
p.
151.
Watt, David C.
1975.
Time to evaluate long-acting neuroleptics?.
Psychological Medicine,
Vol. 5,
Issue. 3,
p.
222.
Mindham, RHS
1976.
Assessment of drugs in schizophrenia. Asessment of drug‐induced extrapyramidal reactions and of drugs given for their control..
British Journal of Clinical Pharmacology,
Vol. 3,
Issue. S2,
p.
395.
Mindham, R.H.S.
1977.
Vol. 1,
Issue. ,
p.
30.
Mindham, R. H. S.
Lamb, Pauline
and
Bradley, Rachel
1977.
A Comparison of Piribedil, Procyclidine and Placebo in the Control of Phenothiazine-induced Parkinsonism.
British Journal of Psychiatry,
Vol. 130,
Issue. 6,
p.
581.
Johnson, D. A. W.
1978.
Prevalence and Treatment of Drug-Induced Extrapyramidal Symptoms.
British Journal of Psychiatry,
Vol. 132,
Issue. 1,
p.
27.
Jenner, P.
and
Marsden, C.D.
1982.
Drugs in Psychiatric Practice.
p.
82.
Wistedt, B.
Wiles, D.
and
J�rgensen, A.
1983.
A depot neuroleptic withdrawal study neurological effects.
Psychopharmacology,
Vol. 80,
Issue. 2,
p.
101.
Bezchlibnyk-Butler, Kalyna Z.
and
Remington, Gary J.
1994.
Antiparkinsonian Drugs in the Treatment of Neuroleptic-Induced Extrapyramidal Symptoms.
The Canadian Journal of Psychiatry,
Vol. 39,
Issue. 2,
p.
74.
Thornley, B
Rathbone, J
Adams, CE
Awad, G
and
Thornley, Ben
2003.
Cochrane Database of Systematic Reviews.
Adams, Clive E
Awad, George
Rathbone, John
Thornley, Ben
and
Adams, Clive E
2007.
Cochrane Database of Systematic Reviews.
Leucht, Claudia
Kitzmantel, Maria
Kane, John
Leucht, Stefan
and
Chua, Wan Lian LC
2008.
Haloperidol versus chlorpromazine for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2013,
Issue. 2,
Wree, Andreas
Mix, Eilhard
Hawlitschka, Alexander
Antipova, Veronica
Witt, Martin
Schmitt, Oliver
and
Benecke, Reiner
2011.
Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease.
Neurobiology of Disease,
Vol. 41,
Issue. 2,
p.
291.
Adams, Clive E
Awad, George A
Rathbone, John
Thornley, Ben
and
Soares-Weiser, Karla
2014.
Chlorpromazine versus placebo for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2015,
Issue. 11,
eLetters
No eLetters have been published for this article.